Published in Eur Arch Otorhinolaryngol on December 01, 2009
Emerging drugs to treat squamous cell carcinomas of the head and neck. Expert Opin Emerg Drugs (2010) 1.25
Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial. BMC Cancer (2013) 1.06
Transoral laser surgery for recurrent glottic cancer after radiotherapy: oncologic and functional outcomes. Acta Otorhinolaryngol Ital (2012) 0.86
Lymph node ratio as a predictor of outcome in patients with oropharyngeal cancer. Eur Arch Otorhinolaryngol (2013) 0.81
Surgery and postoperative radiotherapy a valid treatment for advanced oropharyngeal carcinoma. Eur Arch Otorhinolaryngol (2010) 0.77
The changing role of surgery in the current era of head and neck oncology. Eur Arch Otorhinolaryngol (2013) 0.76
Is open surgery for head and neck cancers truly declining? Eur Arch Otorhinolaryngol (2013) 0.76
Transoral Robotic Surgery in the HPV Era. Rambam Maimonides Med J (2014) 0.75
Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience. Cancer Med (2015) 0.75
When is surgical therapy for head and neck malignant epithelial tumors not indicated? Eur Arch Otorhinolaryngol (2014) 0.75
When is chemotherapy in head and neck squamous cell carcinoma not indicated? Eur Arch Otorhinolaryngol (2014) 0.75
Mini-invasive lateral oropharyngectomy for T3-T4a oropharyngeal cancer. Eur Arch Otorhinolaryngol (2012) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med (2006) 25.67
Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med (2008) 11.86
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst (2008) 8.70
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys (2000) 7.50
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst (1999) 5.15
Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol (2003) 4.53
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst (2004) 3.67
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol (1992) 3.30
Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst (1985) 2.95
Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res (2007) 2.93
Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res (1999) 2.71
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer (2003) 2.69
Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res (2008) 2.66
Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer (2008) 2.62
Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope (2006) 2.45
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol (2009) 2.15
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys (2005) 2.04
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys (2009) 1.88
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol (2001) 1.87
Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.85
Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope (2000) 1.77
Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer (2002) 1.76
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol (2007) 1.66
Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys (2004) 1.64
GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol (2009) 1.60
Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck (2009) 1.53
Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol (2001) 1.51
Photodynamic therapy in the treatment of multiple primary tumours in the head and neck, located to the oral cavity and oropharynx. Clin Otolaryngol (2007) 1.47
A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.39
Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope (2009) 1.37
Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck (2010) 1.34
Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg (2009) 1.31
Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys (2003) 1.31
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys (2007) 1.31
Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol (2007) 1.29
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys (2009) 1.24
Transoral resection of tonsillar squamous cell carcinoma. Laryngoscope (2009) 1.20
Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol (2008) 1.18
Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol (2009) 1.18
HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol (2007) 1.13
Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope (2006) 1.10
Carcinoma of the tongue base treated by transoral laser microsurgery, part one: Untreated tumors, a prospective analysis of oncologic and functional outcomes. Laryngoscope (2006) 1.09
Does surgical resection of pulmonary metastases of head and neck cancer improve survival? Ann Surg Oncol (2008) 1.08
Pulmonary metastasectomy for head and neck cancers. Ann Surg Oncol (1999) 1.07
Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol (2009) 1.06
Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys (1997) 1.03
Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol (2006) 1.03
Transoral robotic assisted free flap reconstruction. Otolaryngol Head Neck Surg (2009) 1.02
Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer. Semin Oncol (2008) 0.98
Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck (1996) 0.94
The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope (2006) 0.93
Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence. Arch Otolaryngol Head Neck Surg (2005) 0.93
Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx. Laryngoscope (2009) 0.92
Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck (2003) 0.92
Transoral laser microsurgery for recurrent laryngeal and pharyngeal cancer. Otolaryngol Head Neck Surg (2008) 0.92
The surgical dilemma of 'functional inoperability' in oral and oropharyngeal cancer: current consensus on operability with regard to functional results. Clin Otolaryngol (2009) 0.92
High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx. Laryngoscope (1999) 0.89
Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx. Cancer (2009) 0.88
Interstitial and external radiotherapy in carcinoma of the soft palate and uvula. Int J Radiat Oncol Biol Phys (1988) 0.88
Feasibility of transoral lateral oropharyngectomy using a robotic surgical system for tonsillar cancer. Oral Oncol (2009) 0.88
T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study. Eur Arch Otorhinolaryngol (2003) 0.87
Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base. Head Neck (2008) 0.84
Effect of radiation techniques in treatment of oropharynx cancer. Laryngoscope (2008) 0.82
A retrospective study of three treatment techniques for T1-T2 base of tongue lesions: surgery plus postoperative radiation, external radiation plus interstitial implantation and external radiation alone. Int J Radiat Oncol Biol Phys (1987) 0.82
Neck dissection followed by radiotherapy or chemoradiotherapy for small primary oropharynx carcinoma with cervical metastasis. Laryngoscope (2005) 0.82
Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck (2007) 0.80
192Ir pharyngoepiglottic fold interstitial implants. The key to successful treatment of base tongue carcinoma by radiation therapy. Cancer (1985) 0.79
Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In regard to Rogers et al. (Int J Radiat Oncol Biol Phys 2004;58:694-697). Int J Radiat Oncol Biol Phys (2005) 0.78
Carcinoma of the tongue base treated by transoral laser microsurgery, part two: Persistent, recurrent and second primary tumors. Laryngoscope (2006) 0.78
Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg (2008) 0.77
The role of human papilloma virus infection in the etiology of oropharyngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg (2005) 0.77
Brachytherapy in the treatment of head and neck cancer. Oncology (Williston Park) (2002) 0.75
Velotonsillar squamous cell carcinoma: 277 cases treated by combined external irradiation and brachytherapy--results according to extension, localization, and dose rate. Int J Radiat Oncol Biol Phys (1992) 0.75
Total glossectomy. Am J Surg (1987) 0.75
The place of brachytherapy in the treatment of carcinoma of the tonsil with lingual extension. Int J Radiat Oncol Biol Phys (1986) 0.75
Salvage brachytherapy and salvage surgery for recurrent oropharyngeal carcinoma following radiotherapy. J Laryngol Otol (1995) 0.75
Total glossectomy without laryngectomy as first-line or salvage therapy. Laryngoscope (2003) 0.75
Surgical management of postradiation residual/recurrent cancer of the base of the tongue. J Surg Oncol (1980) 0.75
Place of Iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas. Int J Radiat Oncol Biol Phys (1993) 0.75
The future of the TNM staging system in laryngeal cancer: time for a debate? Eur Arch Otorhinolaryngol (2008) 2.58
Paragangliomas of the head and neck. Oral Oncol (2004) 2.47
Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol (2009) 2.12
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res (2010) 1.97
Neuroendocrine neoplasms of the larynx: an overview. Head Neck (2009) 1.92
Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol (2006) 1.70
Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg (2008) 1.68
Thyroglossal duct cyst: personal experience and literature review. Auris Nasus Larynx (2007) 1.57
Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys (2007) 1.57
Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol (2012) 1.55
Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 N0 squamous cell carcinoma of the oral tongue. Head Neck (2010) 1.52
Transoral resection of short segment Zenker's diverticulum and cricopharyngeal myotomy: an alternative minimally invasive approach. Laryngoscope (2010) 1.49
Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol (2010) 1.48
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck (2005) 1.45
Sinonasal tumors: a clinicopathologic update of selected tumors. Eur Arch Otorhinolaryngol (2012) 1.43
An outline of the history of head and neck oncology. Oral Oncol (2007) 1.42
Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck? J Am Coll Surg (2005) 1.39
Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol (2002) 1.38
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res (2007) 1.37
Aspergillosis--and a misleading sensitivity result. Lancet (2007) 1.36
Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck (2010) 1.34
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck (2010) 1.34
Advances and applications of oral cancer basic research. Oral Oncol (2011) 1.33
Management of sarcomas of the head and neck in adults. Oral Oncol (2003) 1.31
Evidence-based review of treatment options for patients with glottic cancer. Head Neck (2011) 1.30
Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol (2009) 1.29
Neck disease and distant metastases. Oral Oncol (2003) 1.27
Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol (2010) 1.26
Elective and therapeutic selective neck dissection. Oral Oncol (2005) 1.26
Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck (2004) 1.26
Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck (2007) 1.23
Human papillomavirus infections in laryngeal cancer. Head Neck (2011) 1.22
Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review. Head Neck (2010) 1.20
Surgical margins in head and neck cancer: a contemporary review. Head Neck (2012) 1.19
Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck (2008) 1.18
Endoscopic stapling technique for the treatment of Zenker diverticulum vs standard open-neck technique: a direct comparison and charge analysis. Arch Otolaryngol Head Neck Surg (2002) 1.17
Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2011) 1.16
Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol (2002) 1.16
Management of nasal bone fractures. Am J Otolaryngol (2005) 1.16
Neck dissection: then and now. Auris Nasus Larynx (2006) 1.14
Aggressive variants of papillary thyroid carcinoma. Head Neck (2010) 1.13
Routine drainage after thyroid surgery--a meta-analysis. J Surg Oncol (2007) 1.13